Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Fructose induced lipogenesis: from sugar to fat to insulin resistance.

Samuel VT.

Trends Endocrinol Metab. 2011 Feb;22(2):60-5. doi: 10.1016/j.tem.2010.10.003. Epub 2010 Nov 9. Review.

PMID:
21067942
2.

Fructose as a key player in the development of fatty liver disease.

Basaranoglu M, Basaranoglu G, Sabuncu T, Sentürk H.

World J Gastroenterol. 2013 Feb 28;19(8):1166-72. doi: 10.3748/wjg.v19.i8.1166. Review.

3.

Dietary fructose in nonalcoholic fatty liver disease.

Vos MB, Lavine JE.

Hepatology. 2013 Jun;57(6):2525-31. doi: 10.1002/hep.26299. Epub 2013 May 1. Review.

PMID:
23390127
4.

Effects of Natural Products on Fructose-Induced Nonalcoholic Fatty Liver Disease (NAFLD).

Chen Q, Wang T, Li J, Wang S, Qiu F, Yu H, Zhang Y, Wang T.

Nutrients. 2017 Jan 31;9(2). pii: E96. doi: 10.3390/nu9020096. Review.

5.

From sugar to fat: How the transcription factor XBP1 regulates hepatic lipogenesis.

Glimcher LH, Lee AH.

Ann N Y Acad Sci. 2009 Sep;1173 Suppl 1:E2-9. doi: 10.1111/j.1749-6632.2009.04956.x. Review.

6.

Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.

Softic S, Cohen DE, Kahn CR.

Dig Dis Sci. 2016 May;61(5):1282-93. doi: 10.1007/s10620-016-4054-0. Epub 2016 Feb 8. Review.

7.

Mini review on fructose metabolism.

Akram M, Hamid A.

Obes Res Clin Pract. 2013 Mar-Apr;7(2):e89-e94. doi: 10.1016/j.orcp.2012.11.002. Review.

PMID:
24331770
8.
9.

N-3 polyunsaturated fatty acid regulation of hepatic gene transcription.

Jump DB.

Curr Opin Lipidol. 2008 Jun;19(3):242-7. doi: 10.1097/MOL.0b013e3282ffaf6a. Review.

10.

Does fructose consumption contribute to non-alcoholic fatty liver disease?

Tappy L, Lê KA.

Clin Res Hepatol Gastroenterol. 2012 Dec;36(6):554-60. doi: 10.1016/j.clinre.2012.06.005. Epub 2012 Jul 12. Review.

PMID:
22795319
11.

The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease.

Moore JB, Gunn PJ, Fielding BA.

Nutrients. 2014 Dec 10;6(12):5679-703. doi: 10.3390/nu6125679. Review.

12.

Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.

Ferré P, Foufelle F.

Diabetes Obes Metab. 2010 Oct;12 Suppl 2:83-92. doi: 10.1111/j.1463-1326.2010.01275.x. Review.

PMID:
21029304
13.

Carbohydrate intake and nonalcoholic fatty liver disease.

Neuschwander-Tetri BA.

Curr Opin Clin Nutr Metab Care. 2013 Jul;16(4):446-52. doi: 10.1097/MCO.0b013e328361c4d1. Review.

PMID:
23657151
14.

Fructose, pregnancy and later life impacts.

Regnault TR, Gentili S, Sarr O, Toop CR, Sloboda DM.

Clin Exp Pharmacol Physiol. 2013 Nov;40(11):824-37. doi: 10.1111/1440-1681.12162. Review.

PMID:
24033459
16.

Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease.

Lê KA, Bortolotti M.

Curr Opin Clin Nutr Metab Care. 2008 Jul;11(4):477-82. doi: 10.1097/MCO.0b013e328302f3ec. Review.

PMID:
18542010
17.

[Can the hyperactivity of lipogenesis cause hepatic steatosis? A role for ChREBP].

Robichon C, Girard J, Postic C.

Med Sci (Paris). 2008 Oct;24(10):841-6. doi: 10.1051/medsci/20082410841. Review. French.

18.

De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose.

Sanders FW, Griffin JL.

Biol Rev Camb Philos Soc. 2016 May;91(2):452-68. doi: 10.1111/brv.12178. Epub 2015 Mar 4. Review.

19.

Adverse metabolic effects of dietary fructose: results from the recent epidemiological, clinical, and mechanistic studies.

Stanhope KL, Schwarz JM, Havel PJ.

Curr Opin Lipidol. 2013 Jun;24(3):198-206. doi: 10.1097/MOL.0b013e3283613bca. Review.

20.

The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis.

Herman MA, Samuel VT.

Trends Endocrinol Metab. 2016 Oct;27(10):719-30. doi: 10.1016/j.tem.2016.06.005. Epub 2016 Jul 4. Review.

PMID:
27387598

Supplemental Content

Support Center